Science Corp., the neurotechnology company founded by Max Hodak, is preparing to conduct its first human brain sensor implantation as part of its efforts to develop treatments for neurological conditions.

The brain-computer interface device is designed to address multiple neurological disorders through targeted intervention. According to the company, one of the initial applications being explored involves delivering gentle electrical stimulation to damaged brain or spinal cord cells with the goal of encouraging cellular healing and recovery.

The move represents a significant milestone for Science Corp. as it transitions from development to human trials. Hodak, who previously co-founded Neuralink before departing to start Science Corp., has been working to advance brain-computer interface technology for medical applications.

The success of the device could potentially open new treatment pathways for patients with various neurological conditions, though the company has not disclosed specific timelines for the human trials or detailed information about patient selection criteria.

Brain-computer interface technology has gained increased attention in recent years as companies work to develop solutions for treating conditions ranging from paralysis to depression through direct neural intervention.